Lipid Nanoparticles That Deliver mRNA to T Cells Hold Promise for Autoimmune Diseases

Autoimmune disorders are among the most prevalent chronic diseases across the globe, affecting approximately 5-7% of the world’s population. Emerging treatments for autoimmune disorders focus on “adoptive cell therapies,” or those using cells from a patient’s own body to achieve immunosuppression.